ZA97345B - Novel compounds - Google Patents

Novel compounds

Info

Publication number
ZA97345B
ZA97345B ZA97345A ZA97345A ZA97345B ZA 97345 B ZA97345 B ZA 97345B ZA 97345 A ZA97345 A ZA 97345A ZA 97345 A ZA97345 A ZA 97345A ZA 97345 B ZA97345 B ZA 97345B
Authority
ZA
South Africa
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
ZA97345A
Inventor
Stuart Bailey
Derek Richard Buckle
Andrew Faller
David Glynn Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA97345B publication Critical patent/ZA97345B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
ZA97345A 1996-01-17 1997-01-16 Novel compounds ZA97345B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9601041.8A GB9601041D0 (en) 1996-01-17 1996-01-17 Novel compounds

Publications (1)

Publication Number Publication Date
ZA97345B true ZA97345B (en) 1998-07-16

Family

ID=10787226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA97345A ZA97345B (en) 1996-01-17 1997-01-16 Novel compounds

Country Status (19)

Country Link
EP (1) EP0912545A1 (en)
JP (1) JP2000503312A (en)
KR (1) KR19990077325A (en)
CN (1) CN1213368A (en)
AR (1) AR005472A1 (en)
AU (1) AU725056B2 (en)
BR (1) BR9707024A (en)
CA (1) CA2242913A1 (en)
CZ (1) CZ222498A3 (en)
GB (1) GB9601041D0 (en)
HU (1) HUP9901022A3 (en)
IL (1) IL125381A0 (en)
NO (1) NO983283L (en)
NZ (1) NZ326352A (en)
PL (1) PL327820A1 (en)
TR (1) TR199801380T2 (en)
TW (1) TW462967B (en)
WO (1) WO1997026257A1 (en)
ZA (1) ZA97345B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9609795D0 (en) * 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
WO2000040713A1 (en) * 1999-01-06 2000-07-13 Mcmaster University Method of preventing immune and hypersensitivity reactions
GB9922825D0 (en) * 1999-09-25 1999-11-24 Smithkline Beecham Biolog Medical use
AU2001271068A1 (en) * 2000-07-18 2002-01-30 Chugai Seiyaku Kabushiki Kaisha Matrix metalloprotease inhibitors
WO2003064472A2 (en) * 2002-01-28 2003-08-07 Aimsco Limited Treatment of ms with goat serum
US7521563B2 (en) 2004-08-10 2009-04-21 Shizuoka Coffein Co., Ltd. Hydroxamic acid derivative and medicine containing the same as active ingredient
KR100844277B1 (en) * 2005-04-29 2008-07-07 (주)아모레퍼시픽 A hydroxamic acid derivative and the preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
GB9504084D0 (en) * 1995-03-01 1995-04-19 British Biotech Pharm Synthesis of carboxylic and hydroxamic acid derivatives

Also Published As

Publication number Publication date
IL125381A0 (en) 1999-03-12
HUP9901022A2 (en) 1999-07-28
NZ326352A (en) 2000-03-27
WO1997026257A1 (en) 1997-07-24
AR005472A1 (en) 1999-06-23
CA2242913A1 (en) 1997-07-24
CZ222498A3 (en) 1999-03-17
GB9601041D0 (en) 1996-03-20
NO983283L (en) 1998-09-16
BR9707024A (en) 1999-07-20
JP2000503312A (en) 2000-03-21
KR19990077325A (en) 1999-10-25
NO983283D0 (en) 1998-07-16
AU725056B2 (en) 2000-10-05
TW462967B (en) 2001-11-11
CN1213368A (en) 1999-04-07
HUP9901022A3 (en) 2001-11-28
TR199801380T2 (en) 1998-10-21
EP0912545A1 (en) 1999-05-06
PL327820A1 (en) 1999-01-04
AU1443697A (en) 1997-08-11

Similar Documents

Publication Publication Date Title
EP0914330A4 (en) Novel compounds
EP0961618A4 (en) Novel compounds
EP0909181A4 (en) Novel compounds
GB9601067D0 (en) Novel compounds
EP0904105A4 (en) Novel compounds
AP9701047A0 (en) Novel compounds
GB9605945D0 (en) Novel compounds
GB9600955D0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
GB9605381D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
GB9605883D0 (en) Novel compounds
EP0954525A4 (en) Novel compounds
GB9601068D0 (en) Novel compounds
EP0907377A4 (en) Novel compounds
GB9601066D0 (en) Novel compounds
GB9601099D0 (en) Novel compounds
GB9605154D0 (en) Novel compounds
GB9604584D0 (en) Novel compounds
GB9604574D0 (en) Novel compounds
GB9603655D0 (en) Novel compounds
GB9603654D0 (en) Novel compounds
GB9602679D0 (en) Novel compounds
GB9601235D0 (en) Novel compounds